429 related articles for article (PubMed ID: 33412634)
1. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
2. Clinical Characteristics, Surgical Outcomes, and Prognostic Factors of Intracranial Primary Central Nervous System Lymphoma.
Ouyang T; Wang L; Zhang N; Zhang Z; Xiong Y; Li M; Hong T
World Neurosurg; 2020 Jul; 139():e508-e516. PubMed ID: 32311566
[TBL] [Abstract][Full Text] [Related]
3. Oligodendroglioma resection: a Surveillance, Epidemiology, and End Results (SEER) analysis.
Alattar AA; Brandel MG; Hirshman BR; Dong X; Carroll KT; Ali MA; Carter BS; Chen CC
J Neurosurg; 2018 Apr; 128(4):1076-1083. PubMed ID: 28498059
[TBL] [Abstract][Full Text] [Related]
4. Primary Malignant Melanoma of the Brain: A Population-Based Study.
Puyana C; Denyer S; Burch T; Bhimani AD; McGuire LS; Patel AS; Mehta AI
World Neurosurg; 2019 Oct; 130():e1091-e1097. PubMed ID: 31323401
[TBL] [Abstract][Full Text] [Related]
5. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
[No Abstract] [Full Text] [Related]
6. Clinical outcomes of solitary fibrous tumors and hemangiopericytomas and risk factors related to recurrence and survival based on the 2021 WHO classification of central nervous system tumors.
Wu Y; Zhao T; Cai Y; Zheng M; Zhang Y; Qu Y; Cai Q
J Neurosurg; 2024 Jan; 140(1):69-79. PubMed ID: 37310060
[TBL] [Abstract][Full Text] [Related]
7. Primary central nervous system lymphoma: a profile of 26 cases from Western India.
Agarwal PA; Menon S; Smruti BK; Singhal BS
Neurol India; 2009; 57(6):756-63. PubMed ID: 20139505
[TBL] [Abstract][Full Text] [Related]
8. [Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma].
Song J; Liu H; Shen HL; Yue LZ; Yang XJ; Song WJ; Sun CY; Yu SZ; Ding K; Wang YH; Li LJ; Yu H; Shao YY; Wang CM; Yue SY; Fu R
Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):917-922. PubMed ID: 35045653
[No Abstract] [Full Text] [Related]
9. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and prognostic analysis of 30 cases of primary central nervous system lymphoma].
She C; Tan L; Li P; Ma L; Li W
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):282-5. PubMed ID: 25916286
[TBL] [Abstract][Full Text] [Related]
11. Papillary meningioma of the central nervous system: a SEER database analysis.
Liu F; Tian Y; Zhou L
Neurosurg Rev; 2021 Oct; 44(5):2777-2784. PubMed ID: 33415520
[TBL] [Abstract][Full Text] [Related]
12. [The clinical analysis of primary central nervous system lymphoma in 23 patients].
Piao YZ; Li P; Liu Q; Li WL
Zhonghua Nei Ke Za Zhi; 2011 Nov; 50(11):954-7. PubMed ID: 22333130
[TBL] [Abstract][Full Text] [Related]
13. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands.
van der Sanden GA; Schouten LJ; van Dijck JA; van Andel JP; van der Maazen RW; Coebergh JW;
Cancer; 2002 Mar; 94(5):1548-56. PubMed ID: 11920513
[TBL] [Abstract][Full Text] [Related]
14. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
15. The role of surgical resection in primary central nervous system lymphoma: a single-center retrospective analysis of 70 patients.
Wu S; Wang J; Liu W; Hu F; Zhao K; Jiang W; Lei T; Shu K
BMC Neurol; 2021 May; 21(1):190. PubMed ID: 33975554
[TBL] [Abstract][Full Text] [Related]
16. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
17. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
18. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
19. Incidence, Outcomes and Predictors of Primary Central Nervous System Melanoma: A SEER-Based Study.
Man W; Wang G
World Neurosurg; 2019 Sep; 129():e782-e790. PubMed ID: 31203063
[TBL] [Abstract][Full Text] [Related]
20. Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma.
Teng C; Yang Q; Xiong Z; Ye N; Li X
Front Surg; 2021; 8():764329. PubMed ID: 34888345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
